REFERENCIAS RELACIONADAS

  1. Harmatz P., Mengel K.E., Giugliani R., et al. The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab (2013) 109;1:54–61.
  2. Solanki G.A., Lo W.B., Hendriksz C.J. MRI morphometric characterisation of paediatric cervical spine and spinal cord in children with MPS IVA (Morquio–Brailsford syndrom). J Inherit Metab Dis. (2013) 36;2:329–37.
  3. Montano A.M., Tomatsu S., Gottesman G.S., Smith M., Orii T. International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis (2007) 30:165–174.
  4. White K.K., Harmatz P. Orthopedic management of mucopolysaccharide disease. J Pediatr Rehabil Med. (2010) 3;1:47–56.
  5. Walker R., Belani K.G., Braunlin E.A., et al. Anaesthesia and airway management in mucopolysaccharidosis. J Inherit Metab Dis. 2013 36;2:211.9.
  6. Swiedler S.J., Beck M., Bajbouf M., et al. Threshold Efect of Urinary Glycosaminoglycans and the Walk Test as Indicators of Disease Progression in a Survey of Subjects With Mucopolysaccharidosis VI (Marateaux–Lamy Syndrome). American Journal of Medical Genetics (2005) 134A:144–150.
  7. Arn P., Whitley C., Wraith J.E., Warner Webb H., Underhill L., Rangachari L., Cox G.F. High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry. Journal of Pediatric Surgery (2012) 47:477–484.
  8. Mendelsohn N.J., Wood T., Olson R.A., Temee R., Hale S. Zhang H., Read L. White K.K. Spondyloepiphyseal Dysplasias and Bilateral Legg–Calvë–Perthes Disease: Diagnostic Considerations for Mucopolysaccharidoses. JIMD Rep. (2013) 11:125–32.
  9. Pelley C.J., Kwo J., Hess D.R. Tracheomalacia in an adult with respiratory failure and Morquio syndrome. Respir Care (2007) 52:278–282.
  10. Walker P.P., Rose E., Williams J.G. Upper airways abnormalities and tracheal problems in Morquio’s disease. Thorax (2003) 58:458–459.
  11. Braunlin E.A., Harmartz P.R., Scarpa M., et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011 34;6:1183–97.
  12. Neufeld E.F., Muenzer J.: The Mucopolysaccharidoses. In The Metabolic and Molecular Bases of Inherited Disease Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw–Hill; (2001) 3421–3452.
  13. Northover H., Cowie R.A., Wraith J.E. Mucopolysaccharidosis type IVA (Morquio syndrome): A clinical review. J Inherit Metab Dis. (1996) 19:357–365.
  14. Berger K.I., Fagondes S.C, Giugliani R., et al. Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis. (2013) 36;2:201–10.
  15. Valayannopoulos V., Nicely H., Harmatz P., Turbeville S. Mucopolysaccharidosis VI. Orphanet Journal of Rare Diseases. (2010) 5:5.
  16. Hendriksz C.J., Al–Jawad M., Berger K.I., et al. Clinical overview and treatment options for non–skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis. (2013) 36;2:309–22.
EU/MPS/0269 Junio 2017
EL CONTENIDO DISPONIBLE EN EL SITIO WEB SOLO TIENE FINES INFORMATIVOS Y EDUCATIVOS, Y NO SUSTITUYE EL JUICIO PROFESIONAL DE UN PROFESIONAL SANITARIO A LA HORA DE DIAGNOSTICAR Y TRATAR A LOS PACIENTES. BIOMARIN NO PROPORCIONA CONSEJO MÉDICO, NI TAMPOCO SERVICIOS MÉDICOS O DE DIAGNÓSTICO. LA CONFIANZA EN EL CONTENIDO QUE OBTENGA DE ESTE SITIO WEB O A TRAVÉS DE ÉLQUEDA ÚNICAMENTE BAJO SU RESPONSABILIDAD.